Adenovirus typing rapid identification kit based on nanopore sequencing and application

Through a rapid adenovirus typing identification kit based on nanopore sequencing, using multiple primer system and barcode sequence labeling, the long time and insufficient coverage of adenovirus typing identification in the prior art are solved, and human adenovirus A-G is achieved Rapid and comprehensive typing and identification of more than 100 subgenus simplifies the experimental process and reduces costs.

CN118996009APending Publication Date: 2024-11-22JIANGXI PROVINCIAL CENT FOR DISEASE CONTROL & PREVENTION +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411250167.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-06
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The existing adenovirus typing and identification methods cannot effectively deal with the increasing number of recombinant adenoviruses, and there are defects in the long detection time, the inability to conduct whole-gene sequence analysis, and the inability to identify recombinant typing.

Method used

A rapid identification kit for adenovirus typing based on nanopore sequencing is designed, including a multi-primer system for Hexon, Penton base and Fiber genes, and is labeled with barcode sequence to achieve more than 100 subgenus of human adenovirus A-G. comprehensive classification identification.

Benefits of technology

Rapid typing and identification of adenoviruses was achieved, the experimental process was simplified, the time was controlled within 8 hours, the cost was reduced, and all adenovirus typing of all A-G 7 adenovirus typing were covered.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118996009A_ABST
    Figure CN118996009A_ABST
Patent Text Reader

Abstract

The invention provides an adenovirus typing rapid identification kit based on nanopore sequencing and application, and the adenovirus typing rapid identification kit comprises a first primer pool aiming at a Hexon gene, a second primer pool aiming at a Penton base gene and a third primer pool aiming at a Fiber gene, wherein each group of primer pair in the first primer pool, the second primer pool and the third primer pool is marked by a barcode sequence of a unique label, and a primer system is designed for genes of more than 100 subgenus of A-G typing of the human adenovirus, so that comprehensive typing identification of the adenovirus is expected to be realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of sequencing, and in particular to a rapid identification kit for adenovirus typing based on nanopore sequencing and its application. Background Art

[0002] Human adenovirus (HAdV) is a member of the Adenoviridae family and the genus Mastadenovirus. It can cause a variety of diseases, including common upper or lower respiratory tract infections, gastrointestinal tract or conjunctival infections, and rare infections such as hemorrhagic cystitis, hepatitis, hemorrhagic colitis, pancreatitis, nephritis or encephalitis, appendicitis, etc.

[0003] HAdV is a non-enveloped, linear double-stranded DNA virus with an icosahedral symmetric structure. Its genome size is approximately 34kb to 36kb and its diameter is 70-100nm. The viral capsid is composed of 240 hexon proteins and 12 penton base proteins. Each penton base protein is connected to a fiber protein, which is involved in the attachment process of the virus to the host cell. Hexon protein is an important antigenic protein of HAdV, which can be recognized by neutralizing antibodies and is the basis of virus serum neutralization experiments and type identification. It mainly includes two highly variable ring domains, Loop1 (HVR1-HVR6) and Loop2 (HVR7); Fiber protein contains a handle (Shaft), an N-terminal tail (Nail) and a C-terminal globular domain knot (Knob), among which the Knob region can mediate the interaction between the virus and the host cell; the Penton base protein HVL2 region contains a typical Arg-Gly-Asp (RGD) motif, which can interact with host cell integrins and mediate viral endocytosis.

[0004] Based on biological characteristics, serum neutralization experiments and whole genome sequence characteristics, the International Committee on Taxonomy of Viruses (ICTV) divides adenovirus into 7 subgenera (species, HAdV-AG). There are currently 104 types, of which HAdV-1 to HAdV-52 are serotypes determined based on the different neutralization abilities of HAdV immune sera against the virus. HAdV-53 to HAdV-104 are new recombinant HAdVs renamed based on bioinformatics analysis methods such as whole genome sequences and gene evolution, and are divided into corresponding subgenera based on different viral genome sizes, G+C% content and other characteristics. New types are still emerging.

[0005] HAdV has a wide spectrum of diseases, involving the respiratory tract, gastrointestinal tract, eyes and urogenital tract. Different types of adenovirus have different tissue tropisms and are accompanied by corresponding clinical characteristics, such as: febrile respiratory disease (Acute Respiratory Disease, ARD) (HAdV-B3, E4, B7, B11, B14), epidemic keratoconjunctivitis (EKC) (HAdV-D8, D19, D37, D53, D54), gastrointestinal infection and diarrhea (HAdV-F40, F41, G52), hemorrhagic cystitis (Hemorhagic Cystitis, HC) (HAdV-B34, B35).

[0006] At present, there are mainly the following methods for adenovirus typing and identification: 1. Traditional serological methods: Neutralization test and hemagglutination inhibition test are commonly used typing methods. The neutralization test directly detects the antigenic determinant cluster of the adenovirus hexon protein, and the hemagglutination inhibition test determines the serum based on the detection results of the antigenic determinant cluster of the penton protein. However, this method cannot cope with the increasing number of recombinant adenoviruses, lacks corresponding antibody serum, and has the disadvantage of long detection time; 2. Conventional PCR and quantitative PCR methods: mainly based on the highly variable region of the adenovirus-specific gene hexon, primers and probes are designed according to the characteristics of the nucleic acid sequence of different serotype genes, and typing is performed by amplifying specific target fragments under specific reaction systems and reaction conditions. The disadvantage of this method is that specific primers need to be designed according to each typing, and further gene sequence analysis cannot be performed and recombinant typing cannot be identified. 3. Sequencing technology: There are many types of adenovirus, and the genes between different types vary greatly. Currently, the main method is to design three target genes of different adenovirus types for amplification and then perform first-generation sequencing, or design whole genome primers for certain types for whole genome amplification and sequencing. The defect of this scheme is that whole genome primers can only amplify one or several types at a time, and the type must be determined in advance before amplification and sequencing. For example, Chinese patent CN111808998A discloses an adenovirus whole genome capture method, primer set and kit. This scheme can only target subgenus 3, 7, 11, 14, and 55 in subtype B, and cannot perform typing identification; for example, CN109504803A discloses an RPA method for detecting type 7 human adenovirus, its special primers and probes and uses, and CN110055353A only designs primers for the hexon gene of the B7 subgenus in the adenovirus B subtype, and can only identify whether it is the B7 subgenus. Summary of the invention

[0007] The purpose of the present invention is to provide a rapid identification kit for adenovirus typing based on nanopore sequencing and its application, and to design a primer system for genes of more than 100 subgenera of AG typing of human adenovirus, in order to achieve comprehensive typing and identification of adenovirus.

[0008] To achieve the above objectives, the present technical solution provides a rapid identification kit for adenovirus typing based on nanopore sequencing, comprising: a first primer pool for the Hexon gene, a second primer pool for the Penton base gene, and a third primer pool for the Fiber gene, wherein each primer pair in the first primer pool, the second primer pool, and the third primer pool is labeled by a barcode sequence of a unique tag;

[0009] The first primer pool includes: Hexon_F1 with a sequence such as SEQ ID NO.1, Hexon_F2 with a sequence such as SEQ ID NO.2, Hexon_R1 with a sequence such as SEQ ID NO.3, and Hexon_R2 with a sequence such as SEQ ID NO.4;

[0010] The second primer pool includes: Penton_F1 with a sequence such as SEQ ID NO.5, Penton_F2 with a sequence such as SEQ ID NO.6, Penton_R1 with a sequence such as SEQ ID NO.7, and Penton_R2 with a sequence such as SEQ ID NO.8;

[0011] The third primer pool includes: Fiber_F1 with a sequence such as SEQ ID NO.9, Fiber_F2 with a sequence such as SEQ ID NO.10, Fiber_R1 with a sequence such as SEQ ID NO.11, Fiber_R2 with a sequence such as SEQ ID NO.12, Fiber_R3 with a sequence such as SEQ ID NO.13, and Fiber_F4 with a sequence such as SEQ ID NO.14.

[0012] The adenovirus typing rapid identification kit based on nanopore sequencing provided in this scheme is used for typing and identification of human adenovirus, which can cover all adenovirus typing of more than 100 subgenera of human adenovirus AG. The barcode sequence is used as a molecular tag. After the sample is amplified and mixed sample library is sequenced, the gene sequence of each sample is obtained by splitting the barcode tag and the typing is identified by sequence alignment.

[0013] Specifically, the first primer pool includes two sets of first primer pairs targeting Hexon:

[0014] The forward primer Hexon_F1 with the sequence as SEQ ID NO.1,

[0015] The reverse primer Hexon_R1 has the sequence as SEQ ID NO.3;

[0016] as well as

[0017] The forward primer Hexon_F2 with the sequence as SEQ ID NO.2,

[0018] The reverse primer Hexon_R2 has a sequence as SEQ ID NO.4.

[0019] The second primer pool includes two sets of second primer pairs targeting Penton base genes:

[0020] The forward primer Penton_F1 with the sequence as SEQ ID NO.5,

[0021] The reverse primer Penton_R1 has the sequence of SEQ ID NO.7;

[0022] as well as

[0023] The forward primer Penton_F2 of sequence SEQ ID NO.6,

[0024] The reverse primer Penton_R2 has a sequence as SEQ ID NO.8.

[0025] The third primer pool includes two sets of third primer pairs targeting the Fiber gene:

[0026] The forward primer Fiber_F1 of sequence SEQ ID NO.9,

[0027] The reverse primer Fiber_R1 of sequence SEQ ID NO.11,

[0028] The reverse primer Fiber_R2 has the sequence of SEQ ID NO.12;

[0029] as well as;

[0030] The forward primer Fiber_F2 of sequence SEQ ID NO.10,

[0031] The reverse primer Fiber_R3 of sequence SEQ ID NO.13,

[0032] The reverse primer Fiber_F4 has a sequence as SEQ ID NO.14.

[0033] The first primer pool, the second primer pool and the third primer pool of the adenovirus typing rapid identification kit based on nanopore sequencing provided in this solution together constitute a primer system. The sequence of the primer system is shown in Table 1 below:

[0034] Table 1 Sequence Listing of Primer System

[0035] Serial number sequence name sequence SEQ ID NO.1 Hexon_F1 GGCRTACATGCACATCGCCG SEQ ID NO.2 Hexon_F2 TCGATGATGCCGCARTGGT SEQ ID NO.3 Hexon_R1 CCCATGGACATRAAGTTRCTG SEQ ID NO.4 Hexon_R2 TRGGCTCWTCCATKGGRTC SEQ ID NO.5 Penton_F1 TRGGCTCWTCCATKGGRTC SEQ ID NO.6 Penton_F2 WCTYACCARRGCCATGGC SEQ ID NO.7 Penton_R1 TGATCTGTGAGAGCAGGMACG SEQ ID NO.8 Penton_R2 CGGGAACGTTTTCACTGACG SEQ ID NO.9 Fiber_F1 AWGAHGACTTCAACCCCGT SEQ ID NO.10 Fiber_F2 TYCCYTCYTCCCARCTCTGGT SEQ ID NO.11 Fiber_R1 AGTGARATWCGCATSCGCTG SEQ ID NO.12 Fiber_R2 CGTTTGGCTCGMCAGGARAC SEQ ID NO.13 Fiber_R3 AGSGGKCGTTCAATGGCTA SEQ ID NO.14 Fiber_R4 AAGCTGTGCGTGGGGAGAGA

[0036] In some embodiments, each set of primer pairs is connected to the same barcode sequence, and different sets of primer pairs are connected to different barcode sequences. In this way, after mixed sample library construction and sequencing, the gene sequence of each sample can be obtained by splitting the barcode sequence.

[0037] More specifically, the 5' ends of the primers in the first primer pool, the second primer pool, and the third primer pool are connected to the barcode sequence, that is, the 3' ends of the barcode sequence are connected to the 5' ends of the primers.

[0038] In this scheme, each primer pair corresponds to a unique barcode sequence, and the barcode sequence of each primer pair is selected from one of the following 12:

[0039] Barcode01: CCGTGAC AAGAAAGTTGTCGGTGTCTTTGTG

[0040] Barcode02: CCGTGAC TCGATTCCGTTTGTAGTCGTCTGT

[0041] Barcode03: CCGTGAC GAGTCTTGTGTCCCAGTTACCAGG

[0042] Barcode04: CCGTGAC TTCGGATTCTATCGGTTTCCCTA

[0043] Barcode05: CCGTGAC CTTGTCCAGGGTTTGTGTAACCTT

[0044] Barcode06: CCGTGAC TTCTCGCAAAGGCAGAAAGTAGTC

[0045] Barcode07: CCGTGAC GTGTTACCGTGGGAATGAATCCTT

[0046] Barcode08: CCGTGAC TTCAGGGAACAAACCAAGTTACGT

[0047] Barcode09: CCGTGAC AACTAGGCACAGCGAGTCTTGGTT

[0048] Barcode10: CCGTGAC AAGCGTTGAAACCTTTGCTCCTCTC

[0049] Barcode11: CCGTGAC GTTTCATCTATCGGAGGGAATGGA

[0050] Barcode12: CCGTGAC CAGGTAGAAAGAAGCAGAATCGGA.

[0051] In some embodiments, the adenovirus typing rapid identification kit based on nanopore sequencing of the present scheme is used to type human adenovirus to achieve full typing of AG.

[0052] Of course, in order to achieve full typing of human adenovirus, the adenovirus typing rapid identification kit based on nanopore sequencing provided in this scheme includes: amplification reactants, wherein the amplification reactants include rTaq DNA polymerase, buffer, dNTPs and Mg2+ ions, etc. This scheme selects Hot Start High-Fidelity2X Master Mix was used as the reaction system to improve the specificity and efficiency of PCR amplification.

[0053] In a second aspect, the present invention provides a non-diagnostic method for rapid identification of adenovirus typing based on nanopore sequencing, comprising the following steps:

[0054] Mixing the first primer pool, the second primer pool and the third primer pool to obtain a primer system;

[0055] Mixing the primer system, amplification reactants and the sample to be typed and identified to obtain a reaction system;

[0056] The reaction system is subjected to multi-stage PCR amplification to obtain multiple amplification products;

[0057] Perform mixed-end repair on the amplified product and connect the adapter to obtain a connection product;

[0058] The ligation products were sequenced on a machine to obtain sequencing data, and the sequencing data were split based on the barcode labels and sequence alignment was performed to obtain the typing of the sample to be typed and identified.

[0059] The samples to be typed and identified in this scheme refer to human adenovirus, and the typing includes more than 100 subgenus typing of human adenovirus AG. It should be noted that the typing of adenovirus is mainly determined by three genes: Hexon, Penton base and Fiber. For example, the typing of H3P3F3 is the B3 subtype, belonging to the B subgenus. This scheme amplifies the full length of these three genes at one time, and the specific typing can be obtained through analysis.

[0060] This protocol designs specific primer systems for the Hexon, Penton base and Fiber genes of more than 100 subgenus of adenovirus AG typing, forming the first primer pool, the second primer pool and the third primer pool. When designing primers, a barcode sequence is added to the 5' end of each primer. Multiple samples are amplified by PCR to obtain PCR products with barcode sequences, and then all PCR products are mixed and sequenced. After barcode splitting, the gene sequence of each sample is obtained, and the typing is identified by sequence comparison.

[0061] The PCR amplification program for multi-stage PCR amplification is:

[0062] Initial denaturation: 98°C, 3 min;

[0063] Cycle 1 (5 cycles): 98°C, 30 seconds; 53°C, 20 seconds; 72°C, 2 minutes and 30 seconds;

[0064] Cycle 2 (25 cycles): 98°C, 30 seconds; 58°C, 20 seconds; 72°C, 2 minutes and 30 seconds;

[0065] Final extension: 72°C, 2 min;

[0066] Maintaining temperature: 4°C.

[0067] The PCR amplification program table for multi-stage PCR amplification is shown in Table 2:

[0068] Table 2 PCR amplification program

[0069]

[0070] In some embodiments, Qubit is used to quantify the amplified product, DNA of equal mass to the amplified product is mixed and then end-repair enzyme and buffer are added to obtain a repair system, the repair system is temperature-controlled to perform end-repair to obtain end-repair products, and magnetic beads are used to purify the end-repair products.

[0071] In this protocol, the repair system is placed on a PCR instrument and set to 20°C for 5 min; 65°C for 5 min for temperature control. If a pause is required, the reaction tube can be placed at 4°C for no more than 24 hours to ensure that the end repair enzyme works at an appropriate temperature to complete the end repair task.

[0072] This protocol ensures that the ends of all DNA fragments are blunt ends through end repair, thereby improving the efficiency of ligation between DNA fragments and adapters, thereby increasing the quality and quantity of the final library; at the same time, it can reduce non-specific ligation events caused by end mismatches.

[0073] In some embodiments, the purified end repair product is mixed with a linker ligase to perform a ligation reaction to obtain a ligation product, and the ligation product is purified using magnetic beads.

[0074] In this scheme, the purified end-repair product is mixed with the adapter ligase and incubated at 18-25°C for 10 minutes to achieve a ligation reaction to obtain a ligation product. The adapter ligation step is to connect the end-repaired DNA fragments to the adapter for subsequent sequencing. By using magnetic beads to purify the ligation product, unbound adapters and other impurities can be removed to ensure the quality of the final library. After the connection is completed, the ligation product needs to be purified and quantified to ensure the smooth progress of the subsequent sequencing step.

[0075] Compared with the prior art, this technical solution has the following characteristics and beneficial effects:

[0076] 1. Strong compatibility: The multiple primer system designed by this method covers all AG 7 adenovirus typing and more than 100 subgenera. The three key gene sequences of Hexon, Penton base and Fiber of all adenovirus typing can be obtained by a single amplification.

[0077] 2. Simple experimental process: This method directly adds the barcode to the 5' end of the targeted amplification primer during targeted amplification. After amplification, the samples are directly mixed for single sample library construction and sequencing, which greatly simplifies the experimental process.

[0078] 3. Fast time: Using this method for adenovirus typing and identification, the time from obtaining the sample to sequencing analysis results can be controlled within 8 hours.

[0079] 4. Low cost: This method directly adds the barcode to the 5' end of the targeted amplification primer during targeted amplification. After amplification, the samples are directly mixed for single sample library construction. Only one tube of end repair is required, and the use of barcode and ligase in the process of multi-sample library construction is eliminated. Compared with traditional third-generation sequencing, it greatly saves reagent costs. BRIEF DESCRIPTION OF THE DRAWINGS

[0080] Figure 1 This is an assembly diagram of sequencing data of adenovirus of B3 type.

[0081] Figure 2 This is the assembly diagram of sequencing data of adenovirus of C2 type.

[0082] Figure 3 This is the assembly diagram of sequencing data of adenovirus of D37 type.

[0083] Figure 4 This is an assembly diagram of sequencing data of E4-type adenovirus.

[0084] Figure 5 This is an assembly diagram of sequencing data of adenovirus of F41 type. DETAILED DESCRIPTION

[0085] The following will be combined with the accompanying drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field belong to the scope of protection of the present invention.

[0086] It is to be understood that the term "one" should be understood as "at least one" or "one or more", that is, in one embodiment, the number of an element may be one, while in another embodiment, the number of the element may be multiple, and the term "one" should not be understood as a limitation on the quantity.

[0087] Example:

[0088] 1. Sample source: 11 adenovirus samples from a disease control center, including C1, C2, C5, C6, B3, B7, B55, two strains of F41, E4, and D37 adenovirus;

[0089] 2. Amplification:

[0090] Use Qubit to quantify the sample to be tested, and then prepare the reaction system according to the reaction system shown in Table 3 below:

[0091] Table 3 Reaction system

[0092]

[0093] BarcodePrimer refers to the primer system including the first primer pool, the second primer pool and the third primer pool. Hot Start High-Fidelity 2X Master Mix is ​​a premixed solution for high-fidelity PCR (polymerase chain reaction).

[0094] PCR amplification was performed according to the PCR reaction program shown in Table 4 below:

[0095] Table 4 PCR reaction procedure

[0096]

[0097] Equilibrate the magnetic beads to room temperature in advance, shake and mix, take 25μL and add it to each sample tube containing PCR amplification product, flick to mix and place on a low-speed micro-shaker, incubate at room temperature for 5 minutes; after a brief centrifugation, transfer the liquid in each tube to a new 1.5mL EP tube and place it on a magnetic rack for adsorption. When the liquid becomes clear, maintain the magnetic adsorption state, aspirate the clear liquid and add 200μL WSB along the tube wall. Do not disturb the adsorbed magnetic beads to aspirate the clear liquid, and repeat the magnetic bead adsorption operation.

[0098] Remove the EP tube and centrifuge briefly, then put it back on the magnetic rack to absorb the residual liquid, let it air dry for about 30 seconds (do not let the aggregated magnetic beads dry out), then add 15μL of nuclease-free water to rinse the magnetic beads, remove the EP tube and gently tap to resuspend the magnetic beads, leave it at room temperature for 2 minutes, centrifuge briefly and put it back on the magnetic rack, wait until the solution becomes clear, pipette 14μL and transfer it to a new 1.5mL EP tube, and use Qubit to quantify the purified product.

[0099] 3. End repair:

[0100] Take an equal mass (Qubit quantitative concentration × sampling volume) of DNA and mix it with the PCR product purified by Qubit to obtain mixed DNA, and transfer it to a new 1.5mL EP tube. The total nucleic acid amount is 400ng and the volume is ≤48.5μL. (If it exceeds 48.5μL, it can be purified by 2 times the volume of magnetic beads or concentrated by vacuum drying. If it is insufficient, it can be supplemented with nuclease-free water).

[0101] Add reagent components according to the repair system shown below:

[0102] Table 5 Repair system

[0103] Mixture ingredients volume Mixed DNA 48.5μL End Repair Enzyme (ERE) 3.5μL End Repair Buffer (ERB) 3μL Total volume 55μL

[0104] Place the repair system on a PCR instrument at 20°C for 5 min; at 65°C for 5 min, then take it out. If a pause is required, place it at 4°C for no more than 24 h.

[0105] Equilibrate the magnetic beads to room temperature in advance, shake and mix, take 30μL and add it to each sample tube, flick to mix and place on a low-speed micro-shaker, incubate at room temperature for 5 minutes. After a short centrifugation, transfer the liquid in each tube to a new 1.5mL EP tube and place it on a magnetic stand for adsorption until the liquid becomes clear. Keep the magnetic adsorption state, aspirate the clear liquid, and add 200μL WSB along the tube wall. Do not disturb the adsorbed magnetic beads, aspirate the clear liquid, and repeat the magnetic bead adsorption operation.

[0106] Remove the EP tube, centrifuge briefly, and put it back on the magnetic rack. Remove the residual liquid, air dry for about 30 seconds (do not let the aggregated magnetic beads dry out), then add 48μL of nuclease-free water to rinse the magnetic beads. Remove the EP tube, flick and resuspend the magnetic beads, place at room temperature for 2 minutes, centrifuge briefly, and put it back on the magnetic rack. When the solution becomes clear, pipette 47μL and transfer it to a new 1.5mL EP tube.

[0107] 4. Connector connection:

[0108] Refer to the adapter connection system shown in Table 6 below and add reagents in sequence, flick about 10 times, mix well, centrifuge briefly, and incubate at 18-25℃ for 10 minutes.

[0109] Table 6 Joint connection system

[0110] Mixing ingredients volume End-repair DNA 47μL Adapter sequence mixture (AMX-F) 5μL Ligation Buffer (LNB) 20μL Quick Ligase (QLE) 8μL Total volume 55μL .

[0111] After the magnetic beads are shaken and mixed, 40 μL is added to the adapter connection system, flicked to mix and placed on a low-speed micro-shaker, incubated at room temperature for 5 minutes. After a brief centrifugation, place it on the magnetic rack for adsorption, wait for the liquid to become clear; keep the adsorption state, and aspirate the clear liquid. Remove the EP tube from the magnetic rack, slowly add 200 μL SFB along the side where the magnetic beads are adsorbed, turn the EP tube to gently resuspend the magnetic beads, and then put it back on the magnetic rack (the magnetic beads are not attached to the wall to form aggregates), wait for the liquid to become clear, aspirate the clear liquid, and repeat the operation of magnetic bead adsorption.

[0112] Remove the EP tube and centrifuge briefly, then place it back on the magnetic rack, remove the residual liquid, air dry for about 30 seconds (do not let the aggregated magnetic beads dry out), and add 14μL Elution Buffer (EB) to rinse the magnetic beads. Remove the EP tube and flick to resuspend the magnetic beads, and place at room temperature for 10 minutes. After a brief centrifugation, place it back on the magnetic rack, wait for the liquid to become clear, and transfer 14μL to a new 1.5mL EP tube. Take 1μL of DNA connected to the adapter for Qubit quantification.

[0113] 5. Sequencing on the machine:

[0114] The sequencing was performed on the nanopore sequencer gridion using the Oxford nanopore sequencing kit SQK-LSK110.

[0115] 1) Take 30 μL Flush Tether (FLT) and add Flush Buffer (FB) and mix well.

[0116] 2) Rotate clockwise 90° to open the Priming port, adjust the volume to 200μL with a 1mL gun, vertically contact the Priming port hole and slowly rotate to 230μL to suck out the bubbles in the pipeline. At this time, there is a small amount of liquid at the tip of the gun, indicating that the bubbles in the pipeline have been discharged.

[0117] 3) Use a 1 mL pipette to draw 800 μL of FB, and push it into the pipeline from the Priming port hole at a uniform speed by rotating the pipette volume setting wheel / ring clockwise (or pressing directly). Note that a small amount of liquid remains at the tip of the pipette, and equilibrate the chip at room temperature for another 5 minutes.

[0118] 4) Add the sequencing reagents shown in Table 7 below:

[0119] Table VII Sequencing Reagents

[0120] Mixture ingredients volume Sequencing BufferⅡ(SBⅡ) 37.5μL Loading BeadsⅡ(LBⅡ) 25.5μL DNA library 12μL Total volume 75μL

[0121] 5) After the chip is balanced, open SpotON by gently pushing it outwards to observe whether there are any residual white crystals around the SpotON sample port and the SpotON sample cover (which are easy to remain when used for the second time). If there are any, use a 10μL gun to absorb a small amount of FB to dissolve the white crystals and remove the liquid to avoid bubbles caused by evaporation of the liquid due to loose sealing.

[0122] 6) Use a 1mL pipette to draw up 200μL of FB, and push it into the pipeline at a constant speed from the Priming port hole by rotating the pipette range adjustment wheel / ring clockwise. Be careful to retain a small amount of liquid at the tip of the pipette so that FB flows out of the SpotON sample port and then falls back, thereby rinsing the area around the SpotON sample port.

[0123] 7) Gently pipette up and down the loading sample to mix, take 75 μL and add it dropwise into the SpotON sampleport. The loading beads can be seen to be evenly dispersed.

[0124] 8) First close the SpotON sample cover, then turn counterclockwise to close the Priming port, and finally remove the liquid from the pipeline from Waste port 1. Place it on the sequencer to set up the experiment.

[0125] 6. Data processing:

[0126] The data after sequencing were assembled and compared, proving that the new system can successfully amplify the Hexon, Penton base and Fiber gene sequences of different subtypes of adenovirus under low sample loading conditions (<5ng) and perform rapid identification.

[0127] The present invention is not limited to the above-mentioned optimal implementation mode. Anyone can derive other various forms of products under the inspiration of the present invention. However, no matter what changes are made in the shape or structure, all technical solutions that are the same or similar to those of the present application fall within the protection scope of the present invention.

Claims

1. A rapid identification kit for adenovirus typing based on nanopore sequencing, It is characterized in that include: A first primer pool for Hexon gene, a second primer pool for Penton base gene, and a third primer pool for Fiber gene, wherein each primer pair in the first primer pool, the second primer pool, and the third primer pool is labeled by a barcode sequence of a unique tag; The first primer pool includes: Hexon_F1 with a sequence such as SEQ ID NO.1, Hexon_F2 with a sequence such as SEQ ID NO.2, Hexon_R1 with a sequence such as SEQ ID NO.3, and Hexon_R2 with a sequence such as SEQ ID NO.4; The second primer pool includes: Penton_F1 with a sequence such as SEQ ID NO.5, Penton_F2 with a sequence such as SEQ ID NO.6, Penton_R1 with a sequence such as SEQ ID NO.7, and Penton_R2 with a sequence such as SEQ ID NO.8; The third primer pool includes: Fiber_F1 with a sequence such as SEQ ID NO.9, Fiber_F2 with a sequence such as SEQ ID NO.10, Fiber_R1 with a sequence such as SEQ ID NO.11, Fiber_R2 with a sequence such as SEQ ID NO.12, Fiber_R3 with a sequence such as SEQ ID NO.13, and Fiber_F4 with a sequence such as SEQ ID NO.

14.

2. The adenovirus typing rapid identification kit based on nanopore sequencing according to claim 1, It is characterized in that The first primer pool includes two sets of first primer pairs targeting Hexon: a forward primer Hexon_F1 with a sequence such as SEQ ID NO.1, a reverse primer Hexon_R1 with a sequence such as SEQ ID NO.3; and a forward primer Hexon_F2 with a sequence such as SEQ ID NO.2, a reverse primer Hexon_R2 with a sequence such as SEQ ID NO.

4.

3. The adenovirus typing rapid identification kit based on nanopore sequencing according to claim 1, It is characterized in that The second primer pool includes two sets of second primer pairs targeting the Penton base gene: a forward primer Penton_F1 with a sequence such as SEQ ID NO.5, a reverse primer Penton_R1 with a sequence such as SEQ ID NO.7; and a forward primer Penton_F2 with a sequence such as SEQ ID NO.6, and a reverse primer Penton_R2 with a sequence such as SEQ ID NO.

8.

4. The adenovirus typing rapid identification kit based on nanopore sequencing according to claim 1, It is characterized in that The third primer pool includes two sets of third primer pairs targeting the Fiber gene: a forward primer Fiber_F1 with a sequence such as SEQ ID NO.9, a reverse primer Fiber_R1 with a sequence such as SEQ ID NO.11, and a reverse primer Fiber_R2 with a sequence such as SEQ ID NO.12; and; a forward primer Fiber_F2 with a sequence such as SEQ ID NO.10, a reverse primer Fiber_R3 with a sequence such as SEQ ID NO.13, and a reverse primer Fiber_F4 with a sequence such as SEQ ID NO.

14.

5. The adenovirus typing rapid identification kit based on nanopore sequencing according to claim 1, It is characterized in that Each set of primer pairs is connected to the same barcode sequence, and different sets of primer pairs are connected to different barcode sequences. The barcode sequence of each primer pair is selected from one of the following 12 sequences: Barcode01: CCGTGAC AAGAAAGTTGTCGGTGTCTTTGTG; Barcode02: CCGTGAC TCGATTCCGTTTGTAGTCGTCTGT; Barcode03: CCGTGAC GAGTCTTGTGTCCCAGTTACCAGG; Barcode04: CCGTGAC TTCGGATTCTATCGGTTTCCCTA; Barcode05: CCGTGAC CTTGTCCAGGGTTTGTGTAACCTT; Barcode06: CCGTGAC TTCTCGCAAAGGCAGAAAGTAGTC; Barcode07: CCGTGAC GTGTTACCGTGGGAATGAATCCTT; Barcode08: CCGTGAC TTCAGGGAACAAACCAAGTTACGT; Barcode09: CCGTGAC AACTAGGCACAGCGAGTCTTGGTT; Barcode10: CCGTGAC AAGCGTTGAAACCTTTGCTCCTCTC; Barcode11: CCGTGAC GTTTCATCTATCGGAGGGAATGGA; Barcode12: CCGTGAC CAGGTAGAAAGAAGCAGAATCGGA.

6. The adenovirus typing rapid identification kit based on nanopore sequencing according to claim 1, It is characterized in that Human adenovirus is typed to achieve full typing of AG.

7. The adenovirus typing rapid identification kit based on nanopore sequencing according to claim 1, It is characterized in that include: Amplification reactants used for PCR amplification.

8. A rapid identification kit for adenovirus typing based on nanopore sequencing, It is characterized in that include: The first primer pool, the second primer pool and the third primer pool are mixed to obtain a primer system, wherein each primer pair in the first primer pool, the second primer pool and the third primer pool is labeled by a barcode sequence of a unique tag, Mixing the primer system, amplification reactants and the sample to be typed and identified to obtain a reaction system; The reaction system is subjected to multi-stage PCR amplification to obtain multiple amplification products; Perform mixed-end repair on the amplified product and then connect the adapter to obtain a connection product; The ligation product is sequenced on a machine to obtain sequencing data, and the sequencing data is split based on the barcode label and sequence alignment is performed to obtain the typing of the sample to be typed and identified; The first primer pool includes: Hexon_F1 with a sequence such as SEQ ID NO.1, Hexon_F2 with a sequence such as SEQ ID NO.2, Hexon_R1 with a sequence such as SEQ ID NO.3, and Hexon_R2 with a sequence such as SEQ ID NO.4; The second primer pool includes: Penton_F1 with a sequence such as SEQ ID NO.5, Penton_F2 with a sequence such as SEQ ID NO.6, Penton_R1 with a sequence such as SEQ ID NO.7, and Penton_R2 with a sequence such as SEQ ID NO.8; The third primer pool includes: Fiber_F1 with a sequence such as SEQ ID NO.9, Fiber_F2 with a sequence such as SEQ ID NO.10, Fiber_R1 with a sequence such as SEQ ID NO.11, Fiber_R2 with a sequence such as SEQ ID NO.12, Fiber_R3 with a sequence such as SEQ ID NO.13, and Fiber_F4 with a sequence such as SEQ ID NO.

14.

9. According to the adenovirus typing rapid identification kit based on nanopore sequencing, It is characterized in that The PCR amplification program for multi-stage PCR amplification is: Initial denaturation: 98°C, 3 min; Cycle 1 was performed for 5 cycles, and the conditions of each cycle 1 were: 98°C, 30 seconds; 53°C, 20 seconds; 72°C, 2 minutes and 30 seconds; Cycle 2 was performed for 25 cycles, and the conditions of each cycle 2 were: 98°C, 30 seconds; 58°C, 20 seconds; 72°C, 2 minutes and 30 seconds; Final extension: 72°C, 2 min; Maintain: 4°C.

10. According to the adenovirus typing rapid identification kit based on nanopore sequencing, It is characterized in that The barcode sequence of each primer pair is selected from one of the following 12: Barcode01: CCGTGAC AAGAAAGTTGTCGGTGTCTTTGTG; Barcode02: CCGTGAC TCGATTCCGTTTGTAGTCGTCTGT; Barcode03: CCGTGAC GAGTCTTGTGTCCCAGTTACCAGG; Barcode04: CCGTGAC TTCGGATTCTATCGGTTTCCCTA; Barcode05:CCGTGAC CTTGTCCAGGGTTTGTGTAACCTT; Barcode06:CCGTGAC TTCTCGCAAAGGCAGAAAGTAGTC; Barcode07:CCGTGAC GTGTTACCGTGGGAATGAATCCTT; Barcode08:CCGTGAC TTCAGGGAACAAACCAAGTTACGT; Barcode09:CCGTGAC AACTAGGCACAGCGAGTCTTGGTT; Barcode10:CCGTGAC AAGCGTTGAAACCTTTGTCCTCTC; Barcode11:CCGTGAC GTTTCATCTATCGGAGGGAATGGA; Barcode12:CCGTGAC CAGGTAGAAAGAAGCAGAATCGGA。